Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.
2.

Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance.

Kareva I, Waxman DJ, Lakka Klement G.

Cancer Lett. 2015 Mar 28;358(2):100-6. doi: 10.1016/j.canlet.2014.12.039. Review.

3.

[Metronomic chemotherapy: a new approach in cancer therapy].

Bujak A, Kałas W.

Postepy Hig Med Dosw (Online). 2008 Jul 31;62:364-71. Review. Polish.

4.

Immunological Evasion in Glioblastoma.

Magaña-Maldonado R, Chávez-Cortez EG, Olascoaga-Arellano NK, López-Mejía M, Maldonado-Leal FM, Sotelo J, Pineda B.

Biomed Res Int. 2016;2016:7487313. doi: 10.1155/2016/7487313. Review.

5.
6.

Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma.

Torimura T, Iwamoto H, Nakamura T, Koga H, Ueno T, Kerbel RS, Sata M.

Transl Oncol. 2013 Oct 1;6(5):511-9. Review.

7.

The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field.

Gaspar TB, Henriques J, Marconato L, Queiroga FL.

Vet Comp Oncol. 2017 Mar 20. doi: 10.1111/vco.12309. [Epub ahead of print] Review.

PMID:
28317239

Supplemental Content

Support Center